Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2006. Start Trial.
Date Value
May 31, 2026 30.48%
February 28, 2026 30.05%
November 30, 2025 29.07%
August 31, 2025 31.34%
May 31, 2025 29.44%
February 28, 2025 30.02%
November 30, 2024 29.60%
August 31, 2024 24.80%
May 31, 2024 25.20%
February 29, 2024 25.91%
November 30, 2023 26.09%
August 31, 2023 27.42%
May 31, 2023 25.96%
February 28, 2023 25.60%
November 30, 2022 24.78%
August 31, 2022 23.08%
May 31, 2022 26.71%
February 28, 2022 25.54%
November 30, 2021 26.76%
August 31, 2021 29.31%
May 31, 2021 32.56%
February 28, 2021 34.81%
November 30, 2020 36.17%
August 31, 2020 38.33%
May 31, 2020 34.05%
Date Value
February 29, 2020 32.88%
November 30, 2019 33.37%
August 31, 2019 32.51%
May 31, 2019 33.13%
February 28, 2019 32.38%
November 30, 2018 31.55%
August 31, 2018 31.71%
May 31, 2018 32.14%
February 28, 2018 33.00%
November 30, 2017 34.79%
August 31, 2017 34.86%
May 31, 2017 33.91%
February 28, 2017 33.19%
November 30, 2016 35.55%
August 31, 2016 35.42%
May 31, 2016 35.49%
February 29, 2016 33.90%
November 30, 2015 33.98%
August 31, 2015 33.68%
May 31, 2015 34.45%
February 28, 2015 32.32%
November 30, 2014 32.62%
August 31, 2014 32.26%
May 31, 2014 31.87%
February 28, 2014 31.78%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Sundrug Co., Ltd. 25.72%
AEON Co., Ltd. 35.57%
TSURUHA Holdings, Inc. 30.11%
Sugi Holdings Co., Ltd. 30.84%
COSMOS Pharmaceutical Corp. 20.66%